Multi-disease Carrier Screening Test Validation

Natera, Inc.

Overview

The purpose of this study is to collect blood samples to enable validation of genetic testing for diseases within a multi-disease carrier screening panel. Samples will be collected from adult women or men who have previously tested positive as carriers for various recessive conditions. These are healthy adults who carry a mutation that might place them at increased risk of having a child with a specific genetic disorder. Study participation will be open to adults that were previously tested as part of their routine medical care and where test results demonstrated positive carrier status for a specific genetic disease. Samples will be tested for the disease mutation for which the subjects provides documentation of prior testing.

Study Type

OBSERVATIONAL

Conditions

Spinal Muscular Atrophy (SMA)Carrier Screening Genetic Testing

Interventions

Blood drawPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or older * Individuals who are carriers of an SMN1 deletion consistent with Spinal Muscular Atrophy carrier status and are able to provide documentation of carrier status determined from prior testing * Able to provide a blood sample * Pregnant women may be include in the study Exclusion Criteria: * Minors under the age of 18 years * Individuals who are not carriers of a Spinal Muscular Atrophy mutation * Individuals who are unable to provide documentation of Spinal Muscular Atrophy carrier status.

Locations (1)

Natera, Inc

San Carlos, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.